Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Minutes of the Monetary Policy Meeting held on 27 April 2020

At the monetary policy meeting on 27 April 2020, the Executive Board of the Riksbank decided on continued purchases of government and mortgage bonds up to the end of September 2020 and to leave the repo rate unchanged at zero percent.The board members supported the assessments and analyses presented in the draft Monetary Policy Report. The corona pandemic has hit the world hard and restrictions to curb the spread of infection have substantially reduced activity in the global economy. Developments going forward are extremely uncertain and depend largely on the spread of the virus and the

Invitation to Presentation of SimCorp’s Q1 2020 Interim Report

Press release SimCorp will publish its interim report for Q1 2020 to NASDAQ Copenhagen on Tuesday, May 19, 2020 at around 8:00 am (CEST). SimCorp’s Executive Management Board will present the report at a conference call the same day at 11.00 am (CEST). Please use any of the following phone numbers to dial in to the conference call: From Denmark: +45 3272 0417From USA: + 1 646 741 3167From other countries: +44 (0) 2071 928338Pin code to access the call: 2075116 At the end of the presentation there will be a Q&A session.It will

BioStock: Saniona trailblazing towards market approval

Saniona, currently redeeming the first out of three outstanding warrants, is approaching late-stage clinical studies with lead candidate Tesomet in two eating disorder indications. Meanwhile, partner company Medix is getting ready to launch its licensed asset tesofensine as a new obesity drug following a successful phase III study in Mexico. BioStock had a talk with Saniona’s US based CEO Rami Levin, who after 23 years in the industry will use his experience to attract major US biotech investors to the company.Read the full interview with Rami Levin at biostock.se: https://www.biostock.

Change in Terveystalo's Executive Team

Jens Jensen, Senior Vice President, Corporate Health to leave the company Terveystalo Plc. Stock Exchange Release 11 May 2020 at 10:05 EEST Jens Jensen, Senior Vice President, Corporate Health and a member of the Executive team of Terveystalo, has announced his resignation. Terveystalo has commenced the recruitment of his successor. Tomi Gustafsson Director, Occupational Healthcare and Corporate Customers at Western & Central Finland will serve as interim SVP of Corporate Health from 13 May 2020 until a successor is appointed. "I have had the fortune of taking part in building

Jane’s, the trusted global agency for open-source defence intelligence, announces the appointment of a new Chief Sales Officer

Jane’s is delighted to welcome Susan Michaels to lead Global Sales and Customer CareLONDON (11 May 2020) –– Jane’s, the trusted global agency for open-source defence intelligence, today announced the appointment of Susan Michaels as Chief Sales Officer. Susan will be responsible for accelerating the growth and go-to-market strategy for Jane’s data, open source intelligence and analytics. “I’m excited to be joining Jane’s and for the opportunity to drive the expansion of Jane’s unique data and analysis,” said Susan Michaels, Chief Sales Officer at Jane’s. “I’m passionate about

Iraqi women denied their property by relatives, tribes and militias

Hundreds of thousands of Iraqi women displaced by war remain unable to return to their homes because of systemic injustices that prevent them from proving or claiming ownership of their property. New research by the Norwegian Refugee Council reveals that displaced women are much worse off than men: they are 11 per cent more likely to face barriers impeding them from going back home after years of suffering in displacement camps since the end of the war against Islamic State group in their areas of origin. The barriers include inability to regain access to their property, re-establish

Contracts for CSV’s Far Saga and Normand Energy

Solstad Offshore ASA (“SOFF”) is pleased to announce that the Brazilian flagged CSV, Far Saga, has been awarded a contract with Petróleo Brasileiro S.A. (“Petrobras”) for a period of 3 years firm. Far Saga will be equipped with two Work Class ROVs from C-Innovation suitable for operating to 3.000m water depth. The vessel will keep supporting exploration and production activities in Brazilian continental shelf. Commencement of the Contract shall take place during 3Q 2020. Far Saga has been operating in Brazil since 2014. In addition, the CSV Normand Energy (ex. Normand Seven), has been

NOTICE OF ANNUAL GENERAL MEETING OF LIPIDOR AB (publ)

The shareholders of Lipidor AB (publ) are hereby invited to attend the Annual General Meeting (the “AGM”) to be held on June 11, 2020 at 1.00pm at Karolinska Institutet Science Park, Fogdevreten 2 in Solna. Voting registration will open at 12.30pm and close when the AGM begins.The Company continues to closely monitor the situation in relation to Covid-19, the coronavirus, and shall return with further information closer to the date of the AGM if it is deemed necessary to take any special precautions against contamination in connection with the holding of the AGM. Right to participate

Notice to Annual General Meeting in Scandion Oncology A/S

The Board of Directors of Scandion Oncology A/S (”Scandion Oncology” or the“Company”) convenes the shareholders of Scandion Oncology to the Annual General Meeting, which will be held: Wedensday 27 May 2020, at 4.00 PM at the offices of the Company, Fruebjergvej 3, 2100 København, Denmark. Due to COVID-19 the Board of Directors urges that no shareholder attends the general meeting physically but instead issues a power of attorney to the Board of Directors, vote by correspondence or participates in the general meeting through Microsoft Teams. See further details at the end of this notice.

NOTICE TO THE ANNUAL GENERAL MEETING OF KONECRANES PLC

KONECRANES PLC STOCK EXCHANGE RELEASE 11 MAY 2020 at 09:15 a.m EESTNOTICE TO THE ANNUAL GENERAL MEETING OF KONECRANES PLCNotice is given to the shareholders of Konecranes Plc to the Annual General Meeting to be held on Thursday 11 June 2020 at 10.00 am at the Company’s headquarters at Koneenkatu 8, 05830 Hyvinkää, Finland. Participation and exercise of shareholder rights in the Meeting by shareholders or their proxy representatives is possible only by voting in advance and by submitting counterproposals and asking questions in advance in accordance with the instructions given in this

Finnish lighting manufacturer Aicci gave a novel twist to tables – introducing an elegant table with smart luminaire features

      The Finnish manufacturer of lights Aicci combined the properties of a table and a smart luminaire to introduce Aicci T1 table series developed by the company. The top panel of these elegant tables is a smart control lighting fixture, which can be beautifully illuminated on both sides. The products are manufactured in Muurame, Central Finland.Aicci T1 tables offer a new type of freedom for the furnishing and illumination of areas important for comfort, stimulation or rest. The tables in these design table series with wireless lighting control can lead people into the room,

Elkem ASA – Ex dividend NOK 0.60 today

Oslo, 11 May 2020. The shares in Elkem ASA will be traded ex dividend of NOK 0.60 as of today, 11 May 2020. This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. For further information: Odd-Geir Lyngstad, VP Finance & Investor RelationsTel: +47 976 72 806Email: odd-geir.lyngstad@elkem.no   About Elkem ASA Founded in 1904, Elkem is one of the world's leading suppliers of silicon-based advanced materials with operations throughout the value chain from quartz to specialty silicones, as well as

Lynparza gets broader US ovarian cancer approval

11 May 2020 07:00 BST Lynparza approved in the US as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer Patients treated with Lynparza and bevacizumab lived without disease progression for 37.2 months vs. 17.7 months median for bevacizumab alone One in two women with advanced ovarian cancer has an HRD-positive tumour AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced that Lynparza (olaparib) in combination with bevacizumab has been approved in the US for the

Enhertu designated gastric cancer BTD

11 May 2020 07:00 BST Enhertu granted Breakthrough Therapy Designationin the US for HER2-positive metastatic gastric cancer Second US Breakthrough Therapy Designation for Enhertu AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)'s Enhertu (trastuzumab deruxtecan) has been granted Breakthrough Therapy Designation (BTD) in the US for the treatment of patients with HER2-positive unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma who have received two or more prior regimens including trastuzumab.   Gastric cancer is the third leading

Veidekke ASA: To build school extension in Årsta by Stockholm for SISAB

Veidekke’s subsidiary Arcona has been commissioned to renovate and extend Skanskvarnsskolan in Årsta, just outside Stockholm, for The Stockholm School Properties Company, SISAB. The project is an execution contract with a contract sum of SEK 147 million. Work starts in June and is scheduled to be completed in June 2022.Skanskvarnsskolan is being expanded in order to meet current school building requirements and to accommodate the student body that is expected in the upcoming years. An existing building will be demolished and replaced by a new school building with a gross area of 6,000

Herantis Pharma Plc prepares for next stage of company development by appointing new CEO

Herantis Pharma PlcCompany release, insider information 11 May 2020 at 9:00 AM Eastern European Time Herantis Pharma Plc (“Herantis” or “Company”) announced today that it has appointed Dr. Craig Cook as its new CEO effective 1[st] of July 2020. Pekka Simula, the current CEO, will continue as CEO of Herantis until that date, followed by a three-month handover period during which Mr. Simula will support Dr. Cook in his role through the transition. As a medical doctor with an MBA from the London Business School, Dr. Cook brings more than 20 years of experience in the international

Eurobattery Minerals signs investment agreement with option to acquire the Hautalampi nickel-cobalt-copper mine

Eurobattery Minerals AB (NGM Nordic SME: “BAT”; the “Company”), a growth company in the mining and exploration industry, has signed an investment and shareholders agreement including an option for a staged acquisition of 100 per cent of the shares in Vulcan Hautalampi Oy (“VHOy”), 100 per cent owner of the Hautalampi Nickel-Cobalt-Copper Project, in eastern Finland. The option under the Investment and Shareholders Agreement is linked to an obligation to provide successive cash financing for investments in the Hautalampi nickel-cobalt-copper Project (the “Hautalampi Project”). The

KONECRANES’ BOARD OF DIRECTORS CHANGES ITS DIVIDEND PROPOSAL

KONECRANES PLC inside information MAY 11, 2020 at 9:00 a.m. EESTKOnecranes’ BOARD OF DIRECTORS CHANGES ITS DIVIDEND PROPOSALThe Board of Directors of Konecranes Oyj has decided to convene the Annual General Meeting (AGM) to be held on June 11, 2020. The Notice to convene the AGM will be published as a separate stock exchange release on May 11.As communicated earlier, Konecranes decided to cancel its AGM originally scheduled for March 26, 2020 based on the development of the COVID-19 pandemic and the announcements by the Finnish Government to limit public gatherings. Due to the

Turner Construction Purchases Heliospectra LED Lighting Solutions for Upcoming Greenhouse Projects

(GOTHENBURG, Sweden / TORONTO, Canada / TOKYO, Japan, 11 May, 2020)– Heliospectra AB (publ) (North American ADR OTCQB: HLSPY, and Nasdaq First North Growth Market: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, announces a new order from Turner Construction in Miami, Florida, United States. The order value is USD $270,000.Turner Construction  is leading the design, construction, and installation services for multiple commercial-scale greenhouse projects across the United States in 2020.

Q1 Report 2020 – invitation to conference call and audiocast

On Thursday May 14, at 16.00 CET, IRRAS will host a conference call and an online presentation of its Q1 2020 interim report (which will have been published earlier on the 14[th] at 08.00 CET). The presentation will be held in English. The dial-in numbers for the conference call are:Sweden: +46 8 50 55 83 68Rest of the world: +44 33 33 00 92 61 The presentation will be webcast and can be accessed from the following web address:https://tv.streamfabriken.com/irras-q1-2020 Speakers: President CEO Kleanthis G. Xanthopoulos, Ph.D., CCO Will Martin and CFO Sabina Berlin About

Eurobattery Minerals proposes rights issue of units of approximately SEK 46.5 million

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL, BE SUBJECT TO LEGAL RESTRICTIONS OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES The Board of Directors of Eurobattery Minerals AB (NGM Nordic SME: “BAT”; the “Company”) has proposed to an Extraordinary General Meeting on 27 May 2020 to carry out a rights issue of at most 1,938,938 units (

Orexo acquires exclusive US rights to commercialize deprexis®, a world-leading digital therapy to help patients manage the symptoms of depression

-Scientifically proven digital therapy further strengthens commitment to digital therapeutics -Significant commercial potential -COVID-19 expected to create a significant rise in clinical depression -Leveraging existing US infrastructure Uppsala, Sweden – May 11, 2020. Orexo AB (publ.) today announces it has acquired the exclusive US rights to GAIA AG´s (GAIA) deprexis®, a digital therapy to help patients manage their symptoms of depression and one of the most researched digital therapies in the world. Today’s announcement follows two earlier agreements with GAIA where Orexo

There are no items matching the current filter
There are no more items matching the current filter
Back to top